Volume 17, supplement 5, novembre 2010

mini-revue

Do we have to take into account insulin resistance in chronic hepatitis C ? (p.3-10)
Lawrence Serfaty
Free Access

How to assess fibrosis before antiviral treatment: should we use liver biopsy or non-invasive methods? (p.11-7)
Laurent Castera
Free Access

Can we predict early response to treatment? (p.18-23)
Tarik Asselah, Patrick Marcellin
Free Access

Treatment of naive HCV patients: on the way to a treatment “à la carte” (p.24-9)
Philippe Mathurin
Free Access

Hematopoietic growth factors – place in the antiviral treatment for hepatitis C (p.30-6)
Simona Cosconea, Stanislas Pol
Free Access

What do you do in non responder patients? (p.37-42)
Jean-Pierre Zarski
Free Access

Management of patients with HCV cirrhosis and liver transplant recipients (p.43-50)
Didier Samuel, Bruno Roche
Free Access

Future treatments (p.51-60)
Jean-Michel Pawlotsky
Free Access